Why Iovance Biotherapeutics, Inc. (IOVA) stock fell 11.8% intraday on Friday, October 30, 2026

Iovance Biotherapeutics, Inc. (IOVA) traded at $8.43 as of 10:31 AM ET, down 11.82% on Friday, October 30, 2026, on volume of 9,605,013 shares (0.6× its 3-month average); market value about $3.80B.

IOVA was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for IOVA on Friday, October 30, 2026 or the trading day before (October 29, 2026):

• Oct 29, 2026: SEC 8-K: Other material event source
  Quoted from the filing: “On October 29, 2026, Iovance Biotherapeutics, Inc. (the "Company") issued a press release announcing updated results from Cohorts 1 and 2 of the Company's Phase 2 IOV-LUN-202 trial and a biomarker-enriched precision tumor infiltrating lymphocyte strategy for lifileucel in previously treated non-squamous metastatic non-small-cell lung cancer. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.”

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on IOVA

IOVA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: October 30, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 11:36 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 11:36 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt